The Discounted Cash Flow (DCF) valuation of Royalty Pharma PLC (RPRX) is 40.39 USD. With the latest stock price at 33.78 USD, the upside of Royalty Pharma PLC based on DCF is 19.6%.
Based on the latest price of 33.78 USD and our DCF valuation, Royalty Pharma PLC (RPRX) is a buy. buying RPRX stocks now will result in a potential gain of 19.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 7.3% | 6.3% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 20.24 - 154.18 | 40.39 |
| Upside | -40.1% - 356.4% | 19.6% |